InvestorsHub Logo
Followers 62
Posts 7549
Boards Moderated 1
Alias Born 01/02/2003

Re: CaptBeer post# 424124

Thursday, 05/09/2024 4:40:48 PM

Thursday, May 09, 2024 4:40:48 PM

Post# of 425931
Amarin has the patent on its superior encapsulation, which affords better lab and clinical results than the encapsulation that generics are using.

This introduces the question of whether generic V is really "biosimilar" to Vascepa!...It is something that Amarin or a BP that acquires should explore.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News